Cano Health Inc (CANO)

Ticker: CANO Exchange: NYS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cano Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
23.93
Quantity 97,811 -14.0%
Value US$3,511,082
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
49.41
Quantity 20,913 -26.2%
Value US$2,147,121
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
328.31
Quantity 62,139 -38.5%
Value US$67,353
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.74
Quantity 41,357 -7.1%
Value US$113,471
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.74
Quantity 32,693 -5.3%
Value US$89,736
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.58
Quantity 18,569 -2.9%
Value US$47,960
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.84
Quantity 35,808 -5.4%
Value US$101,612
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.94
Quantity 73,034 -9.9%
Value US$214,800
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.50
Quantity 125,000 -14.4%
Value US$312,762
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
1.91
Quantity 100,000 -10.4%
Value US$191,250
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.92
Quantity 5,987 -0.6%
Value US$17,489
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
2.28
Quantity 94,013 -8.8%
Value US$214,058
ITC Rumba, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.00
Quantity 720,876
Value US$2,162,000
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.30
Quantity 24,171 -100.0%
Value US$79,878
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.59
Quantity 25,000 -50.8%
Value US$89,790
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.73
Quantity 25,000 -33.7%
Value US$93,292
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.75
Quantity 25,000 -25.2%
Value US$93,672
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.82
Quantity 25,000 -20.1%
Value US$95,552
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
3.85
Quantity 25,000 -16.8%
Value US$96,232
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.00
Quantity 13,328 -8.2%
Value US$53,297
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.94
Quantity 24,182 -13.0%
Value US$119,423
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
4.08
Quantity 50,818 -21.4%
Value US$207,251
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.42
Quantity 43,505 -15.5%
Value US$235,658
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.00
Quantity 35,112 -11.1%
Value US$210,644
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.00
Quantity 41,197 -11.5%
Value US$247,227
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.65
Quantity 37,607 -9.5%
Value US$212,370
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.44
Quantity 21,154 -5.1%
Value US$115,124
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.65
Quantity 27,377 -6.2%
Value US$154,787
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
6.62
Quantity 6,309 -1.4%
Value US$41,765
Cooperstone Elliot Large shareholder
Transaction date
Sale
Price
5.67
Quantity 82,843 -15.6%
Value US$469,430
ITC Rumba, LLC 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
11.08
Quantity 532,603
Value US$5,902,000
3.2
Barry S. Sternlicht Affiliate
Transaction date
Proposed sale
Price
12.05
Quantity 176,211
Value US$2,123,343
3.4
Camerlinck Robert Chief Operating Officer Officer
Transaction date
Sale
Price
0.77
Quantity 30,646 -0.1%
Value US$23,453
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.31
Quantity 400,000
Value US$525,745
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.22
Quantity 150,000
Value US$183,300
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.42
Quantity 500,000 -29.2%
Value US$711,650
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.42
Quantity 500,000
Value US$711,650
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.38
Quantity 100,000 -5.5%
Value US$137,760
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.38
Quantity 100,000
Value US$137,760
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.29
Quantity 275,940 -13.2%
Value US$356,156
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.29
Quantity 275,940
Value US$355,963
Aguilar Richard Chief Clinical Officer Officer
Transaction date
Sale
Price
1.32
Quantity 400,000 -21.2%
Value US$528,400
RICHARD B AGUILAR Director Non-Executive Director
Transaction date
Proposed sale
Price
1.32
Quantity 400,000
Value US$528,400
3.1
Armstrong David J See remarks Officer
Transaction date
Sale
Price
1.38
Quantity 3,163 -0.5%
Value US$4,351
1.7
Koppy Brian D Chief Financial Officer Officer
Transaction date
Sale
Price
1.27
Quantity 23,591 -2.9%
Value US$30,067
0.6
Gold Lewis Non-Executive Director
Transaction date
Purchase
Price
6.81
Quantity 300,000 +2023.6%
Value US$2,043,000
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
8.00
Quantity 15,000 +0.5%
Value US$120,000
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
8.75
Quantity 12,500 +0.4%
Value US$109,375
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
9.65
Quantity 8,000 +0.3%
Value US$77,200
0.6
TRUJILLO SOLOMON D Non-Executive Director
Transaction date
Purchase
Price
10.55
Quantity 97,000 +inf%
Value US$1,023,350
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
11.99
Quantity 2,500 +3.8%
Value US$29,975
1.9
Hernandez Marlow CEO and President Executive Director
Transaction date
Purchase
Price
11.99
Quantity 5,833 +0.4%
Value US$69,938
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-02 2024-02-01 S Sale Large shareholder
97,811 -14.0%
23.93
US$3,511,082
97,811 -14.0% 23.93 US$3,511,082
2024-02-02 2024-01-31 S Sale Large shareholder
20,913 -26.2%
49.41
US$2,147,121
20,913 -26.2% 49.41 US$2,147,121
2024-02-02 2024-01-30 S Sale Large shareholder
62,139 -38.5%
328.31
US$67,353
62,139 -38.5% 328.31 US$67,353
2024-01-29 2024-01-29 S Sale Large shareholder
41,357 -7.1%
2.74
US$113,471
41,357 -7.1% 2.74 US$113,471
2024-01-29 2024-01-26 S Sale Large shareholder
32,693 -5.3%
2.74
US$89,736
32,693 -5.3% 2.74 US$89,736
2024-01-29 2024-01-25 S Sale Large shareholder
18,569 -2.9%
2.58
US$47,960
18,569 -2.9% 2.58 US$47,960
2024-01-24 2024-01-24 S Sale Large shareholder
35,808 -5.4%
2.84
US$101,612
35,808 -5.4% 2.84 US$101,612
2024-01-24 2024-01-23 S Sale Large shareholder
73,034 -9.9%
2.94
US$214,800
73,034 -9.9% 2.94 US$214,800
2024-01-24 2024-01-22 S Sale Large shareholder
125,000 -14.4%
2.50
US$312,762
125,000 -14.4% 2.50 US$312,762
2024-01-19 2024-01-18 S Sale Large shareholder
100,000 -10.4%
1.91
US$191,250
100,000 -10.4% 1.91 US$191,250
2024-01-19 2024-01-17 S Sale Large shareholder
5,987 -0.6%
2.92
US$17,489
5,987 -0.6% 2.92 US$17,489
2024-01-19 2024-01-17 S Sale Large shareholder
94,013 -8.8%
2.28
US$214,058
94,013 -8.8% 2.28 US$214,058
2024-01-17 2024-01-17 PrS Proposed sale

10% Stockholder

Large shareholder
720,876
3.00
US$2,162,000
720,876 3.00 US$2,162,000
2024-01-12 2024-01-12 S Sale Large shareholder
24,171 -100.0%
3.30
US$79,878
24,171 -100.0% 3.30 US$79,878
2024-01-12 2024-01-11 S Sale Large shareholder
25,000 -50.8%
3.59
US$89,790
25,000 -50.8% 3.59 US$89,790
2024-01-12 2024-01-10 S Sale Large shareholder
25,000 -33.7%
3.73
US$93,292
25,000 -33.7% 3.73 US$93,292
2024-01-09 2024-01-09 S Sale Large shareholder
25,000 -25.2%
3.75
US$93,672
25,000 -25.2% 3.75 US$93,672
2024-01-09 2024-01-08 S Sale Large shareholder
25,000 -20.1%
3.82
US$95,552
25,000 -20.1% 3.82 US$95,552
2024-01-09 2024-01-05 S Sale Large shareholder
25,000 -16.8%
3.85
US$96,232
25,000 -16.8% 3.85 US$96,232
2024-01-04 2024-01-04 S Sale Large shareholder
13,328 -8.2%
4.00
US$53,297
13,328 -8.2% 4.00 US$53,297
2024-01-04 2024-01-03 S Sale Large shareholder
24,182 -13.0%
4.94
US$119,423
24,182 -13.0% 4.94 US$119,423
2024-01-04 2024-01-03 S Sale Large shareholder
50,818 -21.4%
4.08
US$207,251
50,818 -21.4% 4.08 US$207,251
2024-01-04 2024-01-02 S Sale Large shareholder
43,505 -15.5%
5.42
US$235,658
43,505 -15.5% 5.42 US$235,658
2023-12-29 2023-12-29 S Sale Large shareholder
35,112 -11.1%
6.00
US$210,644
35,112 -11.1% 6.00 US$210,644
2023-12-29 2023-12-28 S Sale Large shareholder
41,197 -11.5%
6.00
US$247,227
41,197 -11.5% 6.00 US$247,227
2023-12-29 2023-12-27 S Sale Large shareholder
37,607 -9.5%
5.65
US$212,370
37,607 -9.5% 5.65 US$212,370
2023-12-26 2023-12-26 S Sale Large shareholder
21,154 -5.1%
5.44
US$115,124
21,154 -5.1% 5.44 US$115,124
2023-12-26 2023-12-22 S Sale Large shareholder
27,377 -6.2%
5.65
US$154,787
27,377 -6.2% 5.65 US$154,787
2023-12-26 2023-12-21 S Sale Large shareholder
6,309 -1.4%
6.62
US$41,765
6,309 -1.4% 6.62 US$41,765
2023-12-26 2023-12-21 S Sale Large shareholder
82,843 -15.6%
5.67
US$469,430
82,843 -15.6% 5.67 US$469,430
2023-12-21 2023-12-21 PrS Proposed sale

10% Stockholder

Large shareholder
532,603
11.08
US$5,902,000
532,603 11.08 US$5,902,000
2023-12-07 2023-12-07 PrS Proposed sale

Affiliate

176,211
12.05
US$2,123,343
176,211 12.05 US$2,123,343
2023-08-15 2023-08-11 S Sale

Chief Operating Officer

Officer
30,646 -0.1%
0.77
US$23,453
30,646 -0.1% 0.77 US$23,453
2023-06-29 2023-06-29 PrS Proposed sale

Director

Non-Executive Director
400,000
1.31
US$525,745
400,000 1.31 US$525,745
2023-06-28 2023-06-28 PrS Proposed sale

Director

Non-Executive Director
150,000
1.22
US$183,300
150,000 1.22 US$183,300
2023-06-13 2023-06-12 S Sale

Chief Clinical Officer

Officer
500,000 -29.2%
1.42
US$711,650
500,000 -29.2% 1.42 US$711,650
2023-06-12 2023-06-12 PrS Proposed sale

Director

Non-Executive Director
500,000
1.42
US$711,650
500,000 1.42 US$711,650
2023-06-13 2023-06-09 S Sale

Chief Clinical Officer

Officer
100,000 -5.5%
1.38
US$137,760
100,000 -5.5% 1.38 US$137,760
2023-06-09 2023-06-09 PrS Proposed sale

Director

Non-Executive Director
100,000
1.38
US$137,760
100,000 1.38 US$137,760
2023-06-13 2023-06-08 S Sale

Chief Clinical Officer

Officer
275,940 -13.2%
1.29
US$356,156
275,940 -13.2% 1.29 US$356,156
2023-06-08 2023-06-08 PrS Proposed sale

Director

Non-Executive Director
275,940
1.29
US$355,963
275,940 1.29 US$355,963
2023-06-13 2023-06-07 S Sale

Chief Clinical Officer

Officer
400,000 -21.2%
1.32
US$528,400
400,000 -21.2% 1.32 US$528,400
2023-06-07 2023-06-07 PrS Proposed sale

Director

Non-Executive Director
400,000
1.32
US$528,400
400,000 1.32 US$528,400
2023-06-07 2023-06-06 S Sale

See remarks

Officer
3,163 -0.5%
1.38
US$4,351
3,163 -0.5% 1.38 US$4,351
2023-04-07 2023-04-05 S Sale

Chief Financial Officer

Officer
23,591 -2.9%
1.27
US$30,067
23,591 -2.9% 1.27 US$30,067
2022-03-21 2022-03-17 B Purchase Non-Executive Director
300,000 +2023.6%
6.81
US$2,043,000
300,000 +2023.6% 6.81 US$2,043,000
2021-12-07 2021-12-06 B Purchase

CEO and President

Executive Director
15,000 +0.5%
8.00
US$120,000
15,000 +0.5% 8.00 US$120,000
2021-12-06 2021-12-03 B Purchase

CEO and President

Executive Director
12,500 +0.4%
8.75
US$109,375
12,500 +0.4% 8.75 US$109,375
2021-11-24 2021-11-22 B Purchase

CEO and President

Executive Director
8,000 +0.3%
9.65
US$77,200
8,000 +0.3% 9.65 US$77,200
2021-11-30 2021-11-18 B Purchase Non-Executive Director
97,000 +inf%
10.55
US$1,023,350
97,000 +inf% 10.55 US$1,023,350
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
2,500 +3.8%
11.99
US$29,975
2,500 +3.8% 11.99 US$29,975
2021-09-02 2021-08-31 B Purchase

CEO and President

Executive Director
5,833 +0.4%
11.99
US$69,938
5,833 +0.4% 11.99 US$69,938